Editas Medicine, Inc.
EDITNASDAQHealthcare● Active
$2.65
$-0.07(-2.40%)
Market Cap$258946127
P/E Ratio—
52W High$4.537
52W Low$1.66
Editas Medicine, Inc.（EDIT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EDIT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $40.52M | $32.31M | $78.12M | $19.71M | $25.54M |
| Cost of Revenue | $0.00M | $0.00M | $6.06M | $6.34M | $5.05M |
| Gross Profit | $40.52M | $32.31M | $72.06M | $13.38M | $20.49M |
| Gross Margin %(computed) | 100.00% | 100.00% | 92.24% | 67.85% | 80.22% |
| Operating Expenses | |||||
| R&D Expenses | $89.95M | $199.25M | $177.65M | $174.96M | $142.51M |
| G&A Expenses | $49.90M | $71.99M | $69.65M | $70.70M | $76.18M |
| Total Operating Expenses | $139.86M | $283.47M | $241.24M | $239.32M | $213.64M |
| Operating Income | ($99.34M) | ($251.15M) | ($169.18M) | ($225.95M) | ($193.15M) |
| Operating Margin %(computed) | -245.15% | -777.22% | -216.56% | — | -756.13% |
| Interest Income | $8.31M | $14.06M | $17.57M | $5.52M | $0.61M |
| Interest Expense | $6.17M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($160.06M) | ($237.09M) | ($153.22M) | ($220.43M) | ($192.50M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($160.06M) | ($237.09M) | ($153.22M) | ($220.43M) | ($192.50M) |
| Net Margin %(computed) | -395.01% | -733.72% | -196.13% | — | -753.61% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 |
| Wtd Avg Shares | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M |
| EBITDA | ($148.61M) | ($233.11M) | ($163.12M) | ($219.61M) | ($188.09M) |
| EBITDA Margin %(computed) | -366.76% | -721.39% | -208.80% | — | -736.35% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Editas Medicine, Inc.
关于Editas Medicine, Inc.（EDIT）损益表
Editas Medicine, Inc.（EDIT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，EDIT实现营收$0.04B，毛利润$0.04B（毛利率100.00%），净利润($0.16B)（净利率-395.01%）。
常见问题
EDIT · 4 问Editas Medicine, Inc.（EDIT）2025财年营收为$0.04B，同比up25.4%。
EDIT revenueEDIT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08